INNO-LiPA® HLA-DQA1
Detects all known alleles of HLA-DQA1 with one amplification and one strip.
INNO-LiPA HLA-DQA1 is a line probe assay for the molecular typing of human leukocyte antigen (HLA) DQA1 alleles at allelic level (DQA1*01–DQA1*06).
CE marked
INNO-LiPA® HLA-DQA1
Product number 80703
20 Tests
INNO-LiPA® HLA-DQA1 Multiplex
Product number 80704
20 Tests
Please contact your local Fujirebio representative for the availability of this product in your country.
Click here to navigate
- Contact sales for information
- Details
- Conditions of sale
- Documentation
- Insights
- FAQ
- Related products
- Product inquiry
-
Details
Features & Benefits
More informative than serology
- INNO-LiPA HLA-DQA1 yields more information on genetic variation
- New alleles mainly appear as new probe patterns, not blanks
Convenient
- Reagents are synthesized and are therefore not limited in quantity
- Reagents are standardized to show minimal batch-to-batch differences
- INNO-LiPA HLA-DQA1 utilizes DNA samples that are easy to transport
- Cell viability or surface expression is not important
Rapid
- INNO-LiPA HLA-DQA1 can be used for large batch analysis
- One technician – one to one hundred samples – one working day
Simple
- The LiPA technique is easy to perform
- Automation is possible using TENDIGO® and Auto-LiPA™ 48
- Objective interpretation of data with LiRAS® for LiPA HLA software
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Other documents
FileFAQ - LIPA General (pdf, 137.77 kb)FileFAQ INNO-LiPA HLA (pdf, 159.58 kb)Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry